PEMZONOX 500MG INJ. at Best Price, Trader, Supplier

PEMZONOX 500MG INJ. Price And Quantity

Price 1950.0 INR/Bottle

Minimum Order Quantity 10 Bottle

PEMZONOX 500MG INJ. Product Specifications

Drug Type [ ' I n t n i o ' j e c ]

Physical Form ' [ L i q u i d ' ]

Suitable For [ ]

Quantity 10 Pieces

Ingredients PEMETROXED FOR INJ.IP

PEMZONOX 500MG INJ. Trade Information

FOB Port Pune

Payment Terms A ) ' , t D e l i v e r y r y C s h A d v a n c e ( C [ ' C a i n s a s h g O D ' C ( C A D ) ' , ' C a s h o n D e l i v e ( a i n A d v a n c e ( C I D ) ' , ' O t h e r A ) ' , ' C a s h s ' ]

Supply Ability 10 Bottle Per Week

Delivery Time 3 Days

Sample Available Yes

Sample Policy [ o r m a t i n o r o ' C o n t a c t u s f i n f r e g a r d i n g o u r s a m p l e p o l i c y ' ]

Main Export Market(s) [ ' A s i a ' ]

Main Domestic Market a ' ] [ ' A l l I n d i

Product Description

Product Description for PEMZONOX 500MG Injection (B2B Market)

Brand Name: PEMZONOX
Strength: 500 mg
Form: Injection
Therapeutic Category: Anticancer, Immunotherapy
Manufacturer: [Manufacturer Name]
Pack Size: Vial (1 vial per pack)

Indication:
PEMZONOX 500mg Injection is indicated for the treatment of certain types of cancers, including:

Non-Small Cell Lung Cancer (NSCLC)
Squamous Cell Carcinoma of the Head and Neck (SCCHN)
Melanoma
Urothelial Carcinoma
Other cancers as per the recommendation of the treating oncologist.

PEMZONOX (Pembrolizumab) is an immune checkpoint inhibitor that works by blocking the PD-1 receptor on immune cells, enhancing the body's immune response to fight cancer.

Mechanism of Action:
PEMZONOX is a monoclonal antibody that targets and blocks the PD-1 (programmed death receptor-1) pathway. PD-1 is a checkpoint receptor on immune cells, which, when activated, suppresses the immune response. By inhibiting PD-1, PEMZONOX allows T-cells to remain active and effectively attack and destroy cancer cells, thus aiding the bodys immune system in recognizing and eliminating tumors.

Dosage and Administration:
PEMZONOX 500mg Injection is administered as an intravenous (IV) infusion. The recommended dosage and frequency of administration depend on the type of cancer being treated, the patient's individual health status, and response to treatment. It is typically given once every 2 to 3 weeks, but this should be determined by the healthcare provider.

Key Features:

Effective Immunotherapy: PEMZONOX is a key drug in immuno-oncology, showing excellent results in treating various types of cancer by boosting the body's own immune system.
Targeted Action: Specifically targets the PD-1 receptor to activate immune responses against tumor cells.
Broad Indications: Proven to be effective across a wide range of cancers.
Well-Researched: Backed by clinical trials and real-world evidence supporting its efficacy and safety.
Revolutionary Treatment: Offers a modern approach to cancer treatment, shifting from traditional chemotherapy to immune-based therapies.

Packaging:
Each vial contains 500 mg of Pembrolizumab in sterile solution, ready for IV administration. Available in packs of [insert number] vials per box.

Storage Instructions:

Store at 2C to 8C (36F to 46F).
Do not freeze.
Keep in the original carton to protect from light.

Contraindications:

Hypersensitivity to Pembrolizumab or any component of the formulation.
Not recommended during pregnancy or breastfeeding unless specifically prescribed.
Caution in patients with autoimmune diseases or history of severe allergic reactions.

Side Effects:
Common side effects may include fatigue, rash, diarrhea, pruritus, and decreased appetite. Serious side effects may include immune-related adverse events such as colitis, pneumonitis, hepatitis, and endocrinopathies.

Regulatory Status:
Approved by [Relevant Health Authority/Agency].

For wholesale inquiries, distribution, or B2B partnerships, please contact our sales team at [Contact Details].

Note: Always consult with a healthcare provider for proper diagnosis and treatment before administering PEMZONOX.